Home Cart Sign in  
Chemical Structure| 28697-07-6 Chemical Structure| 28697-07-6
Chemical Structure| 28697-07-6

*Storage: Sealed in dry,Room Temperature.

*Shipping: Normal

1-Carbobenzoxy-2-piperidinecarboxylic Acid

CAS No.: 28697-07-6

4.5 *For Research Use Only !

Cat. No.: A205730 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
5g łÇ§¶ÊÊ Inquiry Inquiry Login
25g ł§§¶ÊÊ Inquiry Inquiry Login
100g łÇÇÿ¶ÊÊ Inquiry Inquiry Login
500g łÍÇò¶ÊÊ Inquiry Inquiry Login

Please Login or Create an Account to: See VIP prices and availability

  • 5g

    łÇ§¶ÊÊ

  • 25g

    ł§§¶ÊÊ

  • 100g

    łÇÇÿ¶ÊÊ

  • 500g

    łÍÇò¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 28697-07-6 ]

CAS No. :28697-07-6
Formula : C14H17NO4
M.W : 263.29
SMILES Code : O=C(C1N(C(OCC2=CC=CC=C2)=O)CCCC1)O
MDL No. :MFCD01863568
InChI Key :ZSAIHAKADPJIGN-UHFFFAOYSA-N
Pubchem ID :4431026

Safety of [ 28697-07-6 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 28697-07-6 ] Show Less

Physicochemical Properties

Num. heavy atoms 19
Num. arom. heavy atoms 6
Fraction Csp3 0.43
Num. rotatable bonds 5
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 73.2
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

66.84 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.29
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.1
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.73
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.57
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.28
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.79

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.7
Solubility 0.526 mg/ml ; 0.002 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.13
Solubility 0.193 mg/ml ; 0.000734 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.36
Solubility 1.15 mg/ml ; 0.00436 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.42 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.74

Application In Synthesis [ 28697-07-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 28697-07-6 ]

[ 28697-07-6 ] Synthesis Path-Downstream   1~4

  • 2
  • [ 28697-07-6 ]
  • [ 74-88-4 ]
  • [ 180609-56-7 ]
YieldReaction ConditionsOperation in experiment
93% With potassium hydrogencarbonate; In N,N-dimethyl-formamide; at 20℃; for 18h; EXAMPLE 36; 2-(2-methylpiperidin-2-yl)-1H-benzimidazole-4-carboxamide; EXAMPLE 36A; 1-benzyl 2-methyl piperidine-1,2-dicarboxylate A solution of 1-[(benzyloxy)carbonyl]piperidine-2-carboxylic acid (5 g) and iodomethane (2.5 mL) in DMF (40 mL) was treated with potassium bicarbonate (3.8 g) and stirred at room temperature for 18 hrs. The reaction mixture was concentrated and the residual oil was partitioned between ethyl acetate and water. The organic phase was concentrated and the residue was purified by flash chromatography (silica gel, ethyl acetate/hexanes) to provide Example 36A (4.88 g, Yield: 93%). MS (DCI/NH3) m/z 278 (M+H)+.
  • 3
  • [ 28697-07-6 ]
  • [ 14252-80-3 ]
  • 4
  • [ 67-56-1 ]
  • [ 28697-07-6 ]
  • [ 180609-56-7 ]
YieldReaction ConditionsOperation in experiment
61% To a solution of 9.41 g (1 eq.) l-(Benzyloxycarbonyl)-2-piperidinecarboxylic acid in 200 mL DCM 0.6 g HOBt (0.11 eq.) and 7.45 g (1.1 eq.) EDC hydrochloride were added and the mixture was stirred vigorously at ambient temperature for 1.5 h. To the solution was added 40 mL methanol. The mixture was stirred overnight, extracted with water, and the organic phase dried over magnesium sulfate. The dry solution was filtered and concentrated in vacuum. The resulting residue was purified by chromatography (ethyl acetate/nTieptane 1 : 1), yielding 6.6 g of the title compound as colorless oil (yield 61%).
 

Related Products

Technical Information

Categories

Related Functional Groups of
[ 28697-07-6 ]

Aryls

Chemical Structure| 28697-11-2

A183829 [28697-11-2]

(S)-1-N-Cbz-Pipecolinic acid

Similarity: 1.00

Chemical Structure| 180609-56-7

A212019 [180609-56-7]

Methyl N-Cbz-piperidine-2-carboxylate

Similarity: 0.97

Chemical Structure| 126401-22-7

A130496 [126401-22-7]

1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate

Similarity: 0.96

Chemical Structure| 151004-88-5

A169061 [151004-88-5]

(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid

Similarity: 0.92

Chemical Structure| 63845-33-0

A177627 [63845-33-0]

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid

Similarity: 0.87

Amides

Chemical Structure| 28697-11-2

A183829 [28697-11-2]

(S)-1-N-Cbz-Pipecolinic acid

Similarity: 1.00

Chemical Structure| 180609-56-7

A212019 [180609-56-7]

Methyl N-Cbz-piperidine-2-carboxylate

Similarity: 0.97

Chemical Structure| 126401-22-7

A130496 [126401-22-7]

1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate

Similarity: 0.96

Chemical Structure| 151004-88-5

A169061 [151004-88-5]

(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid

Similarity: 0.92

Chemical Structure| 63845-33-0

A177627 [63845-33-0]

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid

Similarity: 0.87

Carboxylic Acids

Chemical Structure| 28697-11-2

A183829 [28697-11-2]

(S)-1-N-Cbz-Pipecolinic acid

Similarity: 1.00

Chemical Structure| 151004-88-5

A169061 [151004-88-5]

(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid

Similarity: 0.92

Chemical Structure| 63845-28-3

A130529 [63845-28-3]

2-(1-((Benzyloxy)carbonyl)piperidin-4-yl)acetic acid

Similarity: 0.87

Chemical Structure| 63845-33-0

A177627 [63845-33-0]

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid

Similarity: 0.87

Chemical Structure| 321983-19-1

A222484 [321983-19-1]

1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid

Similarity: 0.86

Related Parent Nucleus of
[ 28697-07-6 ]

Aliphatic Heterocycles

Chemical Structure| 28697-11-2

A183829 [28697-11-2]

(S)-1-N-Cbz-Pipecolinic acid

Similarity: 1.00

Chemical Structure| 180609-56-7

A212019 [180609-56-7]

Methyl N-Cbz-piperidine-2-carboxylate

Similarity: 0.97

Chemical Structure| 126401-22-7

A130496 [126401-22-7]

1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate

Similarity: 0.96

Chemical Structure| 63845-28-3

A130529 [63845-28-3]

2-(1-((Benzyloxy)carbonyl)piperidin-4-yl)acetic acid

Similarity: 0.87

Chemical Structure| 63845-33-0

A177627 [63845-33-0]

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid

Similarity: 0.87

Piperidines

Chemical Structure| 28697-11-2

A183829 [28697-11-2]

(S)-1-N-Cbz-Pipecolinic acid

Similarity: 1.00

Chemical Structure| 180609-56-7

A212019 [180609-56-7]

Methyl N-Cbz-piperidine-2-carboxylate

Similarity: 0.97

Chemical Structure| 126401-22-7

A130496 [126401-22-7]

1-Benzyl 2-ethyl piperidine-1,2-dicarboxylate

Similarity: 0.96

Chemical Structure| 63845-28-3

A130529 [63845-28-3]

2-(1-((Benzyloxy)carbonyl)piperidin-4-yl)acetic acid

Similarity: 0.87

Chemical Structure| 63845-33-0

A177627 [63845-33-0]

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)propanoic acid

Similarity: 0.87